By David Cassak
Published in the March 13, 2015 Issue (Vol. 2, No. 5)
In this commentary piece by The MedTech Strategist’s Co-Editor-in-Chief, David Cassak considers the current trend toward opportunistic medtech investing and the value of opportunity defined by commitment.
Venture dollars going to medical devices, while nowhere near its high of the mid-2000s, has actually been holding steady for the past several years. But there appears to have been a subtle shift in venture investing in medical devices, a shift from a commitment to what might be called a more opportunistic approach to device deals. Clearly some venture firms have drifted away from medtech, while others have cut back. But even many of those who continue to invest in devices are doing so opportunistically rather than as a part of a larger strategy, jumping in where they see what they believe is a good deal, but just as glad to sit on the sidelines.
Those who stay in the game are convinced, precisely because there is still lots of great technology out there and great entrepreneurs bringing it forward, that they see opportunities where others can’t.